COVID-19

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

GARDEN CITY, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…

1 year ago

Hemostemix is Up-Listing in the USA to Generate Liquidity

Calgary, Alberta--(Newsfile Corp. - January 2, 2025) -   Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

1 year ago

BioStem Technologies CEO to Present at Biotech Showcase 2025

Presentation to be webcast at 2:30 PM PT on Monday, January 13, 2025POMPANO BEACH, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE)…

1 year ago

Hemostemix’s Social Media Awareness of “Your Fountain of Youth”(TM) Regenerative Medicine Treatments Is Gaining Traction

Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals…

1 year ago

Australia’s Digital Health Transformation: Black Book Research Reveals 2025 EHR Vendor Rankings and Insights

Oracle Health Secures Top Spot in Australia's 2025 EHR Rankings for Excellence in Innovation and Interoperability MELBOURNE, AU / ACCESSWIRE…

1 year ago

WEED Inc. President and CEO Releases Letter to Shareholders

TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a…

1 year ago

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

CHICAGO, IL / ACCESSWIRE / December 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies

Coeptis Aims to Bring AI Innovation in Biotechnology and Technology WEXFORD, Pa., Dec. 26, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings,…

1 year ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today,…

1 year ago